Zoetis (NYSE: ZTS)
Zoetis Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zoetis Company Info
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.
News & Analysis
3 Magnificent S&P 500 Dividend Stocks Down 19% to 26%: Is It Time to Buy the Dip?
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Steady growth and dividend increases over decades can make investors remarkably wealthy.
2 Recession-Proof Stocks to Buy and Hold
Beat the S&P 500 With This Cash-Gushing Dividend Stock
The business may be somewhat boring, but it consistently delivers year after year, resulting in tremendous long-term returns.
2 Dividend Stocks to Buy With $500 and Hold Forever
1 Superstar Dividend Growth Stock to Buy if the Market Crashes
Investors have been waiting nearly a decade to score a good deal on this healthcare star.
3 Magnificent Stocks to Buy That Are Near 52-Week Lows
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years
Valuation
Podcast Episodes
Earnings Transcripts
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
ZTS earnings call for the period ending December 31, 2024.
Zoetis (ZTS) Q3 2024 Earnings Call Transcript
ZTS earnings call for the period ending September 30, 2024.
Zoetis (ZTS) Q2 2024 Earnings Call Transcript
ZTS earnings call for the period ending June 30, 2024.
Zoetis (ZTS) Q1 2024 Earnings Call Transcript
ZTS earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.